The University of Pennsylvania, Philadelphia, PA 19104, United States.
Int J Law Psychiatry. 2020 May-Jun;70:101562. doi: 10.1016/j.ijlp.2020.101562. Epub 2020 Apr 21.
The extent to which psychiatric diagnosis, treatment compliance, and violence risk influenced judges perceived benefits of Mental Health Court ("MHC") for defendants with psychiatric disorders was examined.
81 judges completed one vignette in which psychiatric diagnosis (Schizophrenia, Major Depressive Disorder, Posttraumatic Stress Disorder), treatment compliance (yes/no), and violence risk (high/low) were randomized. The online survey was distributed via email and following the vignette, judges answered a question about the appropriateness of MHC.
Judges assessed defendants with severe psychiatric disorders (Schizophrenia and Major Depressive Disorder) - compared to defendants with PTSD - as more likely to benefit from MHCs. If deemed at low treatment compliance and/or high violence risk, judges were unlikely to appraise MHCs as beneficial, regardless of psychiatric diagnosis.
Judges appear to consider relevant factors when determining whether MHC will benefit defendants with psychiatric disorders; however, future research should include more variables (e.g., addictions, history of violence) to examine the combined influence on judges' perception of MHC suitability.
研究精神病诊断、治疗依从性和暴力风险在多大程度上影响法官对精神健康法庭(MHC)对患有精神障碍的被告的益处的看法。
81 名法官完成了一个病例,其中精神病诊断(精神分裂症、重度抑郁症、创伤后应激障碍)、治疗依从性(是/否)和暴力风险(高/低)是随机的。在线调查通过电子邮件分发,在病例之后,法官回答了一个关于 MHC 是否合适的问题。
与 PTSD 患者相比,法官认为患有严重精神障碍(精神分裂症和重度抑郁症)的被告更有可能从 MHC 中受益。如果被认为治疗依从性低和/或暴力风险高,法官不太可能认为 MHC 有益,而不论精神病诊断如何。
法官在确定 MHC 是否有益于患有精神障碍的被告时,似乎会考虑相关因素;然而,未来的研究应包括更多变量(例如,成瘾、暴力史),以检查它们对法官对 MHC 适用性的看法的综合影响。